Updates on the Role of Probiotics against Different Health Issues: Focus on Lactobacillus

This review article is built on the beneficial effects of Lactobacillus against different diseases, and a special focus has been made on its effects against neurological disorders, such as depression, multiple sclerosis, Alzheimer’s, and Parkinson’s disease. Probiotics are live microbes, which are found in fermented foods, beverages, and cultured milk and, when administered in an adequate dose, confer health benefits to the host. They are known as “health-friendly bacteria”, normally residing in the human gut and involved in maintaining homeostatic conditions. Imbalance in gut microbiota results in the pathophysiology of several diseases entailing the GIT tract, skin, immune system, inflammation, and gut–brain axis. Recently, the use of probiotics has gained tremendous interest, because of their profound effects on the management of these disease conditions. Recent findings suggest that probiotics enrichment in different human and mouse disease models showed promising beneficial effects and results in the amelioration of disease symptoms. Thus, this review focuses on the current probiotics-based products, different disease models, variable markers measured during trials, and evidence obtained from past studies on the use of probiotics in the prevention and treatment of different diseases, covering the skin to the central nervous system diseases.

[1]  Laping He,et al.  Characterization, High-Density Fermentation, and the Production of a Directed Vat Set Starter of Lactobacilli Used in the Food Industry: A Review , 2022, Foods.

[2]  M. Kim,et al.  Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants , 2022, Cells.

[3]  A. Kusiak,et al.  Probiotics: Should All Patients Take Them? , 2021, Microorganisms.

[4]  G. L. Garrote,et al.  Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains , 2021, Foods.

[5]  M. Kim,et al.  Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ1–42-Induced Alzheimer’s Disease , 2021, International journal of molecular sciences.

[6]  M. Kim,et al.  Antioxidative and Anti-inflammatory Effects of Kojic Acid in Aβ-Induced Mouse Model of Alzheimer’s Disease , 2021, Molecular Neurobiology.

[7]  Hyoung-Gon Lee,et al.  Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer’s disease , 2021, Molecular neurodegeneration.

[8]  H. Hsieh-Li,et al.  Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease , 2020, Brain, Behavior, and Immunity.

[9]  Y. Probst,et al.  Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review. , 2020, Advances in nutrition.

[10]  C. Patel,et al.  Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

[11]  S. Govoni,et al.  Targeting the microbiota in pharmacology of psychiatric disorders. , 2020, Pharmacological research.

[12]  H. Szajewska,et al.  Use of Probiotics for the Management of Acute Gastroenteritis in Children. An Update. , 2020, Journal of pediatric gastroenterology and nutrition.

[13]  J. Sim,et al.  Regulatory effects of Lactobacillus plantarum HY7714 on skin health by improving intestinal condition , 2020, PloS one.

[14]  F. He,et al.  Long-term combined administration of Bifidobacterium bifidum TMC3115 and Lactobacillus plantarum 45 alleviates spatial memory impairment and gut dysbiosis in APP/PS1 mice. , 2020, FEMS microbiology letters.

[15]  F. Tabandeh,et al.  The effect of lactobacillus cell size on its probiotic characteristics. , 2020, Anaerobe.

[16]  M. Salami,et al.  Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease , 2019, Behavioural Brain Research.

[17]  Pei Jiang,et al.  Oral treatment with Lactobacillus reuteri attenuates depressive-like behaviors and serotonin metabolism alterations induced by chronic social defeat stress. , 2019, Journal of psychiatric research.

[18]  Z. Pirtošek,et al.  Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies , 2019, Front. Neurol..

[19]  D. Chung,et al.  Combination treatment with lipoteichoic acids isolated from Lactobacillus plantarum and Staphylococcus aureus alleviates atopic dermatitis via upregulation of CD55 and CD59. , 2019, Immunology letters.

[20]  You-jin Jang,et al.  Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis , 2019, Frontiers in molecular biosciences.

[21]  M. Salami,et al.  The Effects of Probiotic Lactobacillus and Bifidobacterium Strains on Memory and Learning Behavior, Long-Term Potentiation (LTP), and Some Biochemical Parameters in β-Amyloid-Induced Rat’s Model of Alzheimer’s Disease , 2019, Preventive nutrition and food science.

[22]  P. Han,et al.  Extracellular Vesicles Derived from Lactobacillus plantarum Increase BDNF Expression in Cultured Hippocampal Neurons and Produce Antidepressant-like Effects in Mice , 2019, Experimental neurobiology.

[23]  Joseph D. Gardinier,et al.  Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  Jin-zhong Xiao,et al.  Heat-killed Lactobacillus helveticus strain MCC1848 confers resilience to anxiety or depression-like symptoms caused by subchronic social defeat stress in mice , 2019, Bioscience, biotechnology, and biochemistry.

[25]  M. Liong,et al.  Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study. , 2019, Beneficial microbes.

[26]  Christopher M. Taylor,et al.  Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota , 2019, Front. Immunol..

[27]  R. Froissart,et al.  Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics , 2019, Scientific Reports.

[28]  S. Pongor,et al.  Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiome , 2019, Experimental Gerontology.

[29]  Enass Y. Osman,et al.  Comparative therapeutic efficacy study of Lactobacilli probiotics and citalopram in treatment of acute stress-induced depression in lab murine models , 2018, Human Microbiome Journal.

[30]  M. Azad,et al.  Immunomodulatory Effects of Probiotics on Cytokine Profiles , 2018, BioMed research international.

[31]  D. Pietrella,et al.  Anti-inflammatory effect of multistrain probiotic formulation (L. rhamnosus, B. lactis, and B. longum). , 2018, Nutrition.

[32]  Alexandra Papadopoulou,et al.  Efficacy of an Oral Rehydration Solution Enriched with Lactobacillus reuteri DSM 17938 and Zinc in the Management of Acute Diarrhoea in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial , 2018, Nutrients.

[33]  M. Tremblay,et al.  Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions? , 2018, Front. Cell. Neurosci..

[34]  Hongwei Zhou,et al.  Gut microbiota in patients with Parkinson's disease in southern China. , 2018, Parkinsonism & related disorders.

[35]  P. Aich,et al.  Probiotics L. acidophilus and B. clausii Modulate Gut Microbiota in Th1- and Th2-Biased Mice to Ameliorate Salmonella Typhimurium-Induced Diarrhea , 2018, Probiotics and Antimicrobial Proteins.

[36]  H. Weiner,et al.  A probiotic modulates the microbiome and immunity in multiple sclerosis , 2018, Annals of neurology.

[37]  Y. Huh,et al.  Probiotic Lactobacillus sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model , 2018, Front. Microbiol..

[38]  R. McIntyre,et al.  Targeting cytokines in reduction of depressive symptoms: A comprehensive review , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[39]  T. Chun,et al.  Oral administration of Lactobacillus plantarum CJLP133 and CJLP243 alleviates birch pollen‐induced allergic rhinitis in mice , 2018, Journal of applied microbiology.

[40]  H. Lassmann Multiple Sclerosis Pathology. , 2018, Cold Spring Harbor perspectives in medicine.

[41]  M. Safa,et al.  Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1-42) injected rats. , 2018, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[42]  C. Blondeau,et al.  Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice. , 2018, Beneficial microbes.

[43]  M. Murakami,et al.  Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice , 2018, Front. Microbiol..

[44]  Young-Seo Park,et al.  Potential probiotic Lactobacillus plantarum Ln4 from kimchi: Evaluation of β-galactosidase and antioxidant activities , 2017 .

[45]  M. Mahmoudi,et al.  Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[46]  Junling Shi,et al.  Identification, characterization, and probiotic potential of Lactobacillus rhamnosus isolated from human milk , 2017 .

[47]  M. Salami,et al.  Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. , 2017, Clinical nutrition.

[48]  E. Mitchell,et al.  Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial , 2017, EBioMedicine.

[49]  K. Śliżewska,et al.  Effects of Probiotics, Prebiotics, and Synbiotics on Human Health , 2017, Nutrients.

[50]  J. Gordon,et al.  Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells , 2017, Science.

[51]  Mallikarjuna Nimgampalle,et al.  Anti-Alzheimer Properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's Disease induced Albino Rats. , 2017, Journal of clinical and diagnostic research : JCDR.

[52]  G. Deuschl,et al.  Gut microbiota in Parkinson disease in a northern German cohort , 2017, Brain Research.

[53]  K. Nightingale,et al.  Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health , 2017, Journal of applied microbiology.

[54]  Francisco Javier Ruiz-Ojeda,et al.  Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases , 2017, Nutrients.

[55]  M. Mimura,et al.  Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data , 2017, Psychopharmacology.

[56]  Luis Pedro Coelho,et al.  Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.

[57]  V. Azevedo,et al.  Evaluation of Potential Probiotics Isolated from Human Milk and Colostrum , 2017, Probiotics and Antimicrobial Proteins.

[58]  Ramón Cacabelos,et al.  Parkinson’s Disease: From Pathogenesis to Pharmacogenomics , 2017, International journal of molecular sciences.

[59]  Shengyu Li,et al.  Reduction of Aflatoxin B1 Toxicity by Lactobacillus plantarum C88: A Potential Probiotic Strain Isolated from Chinese Traditional Fermented Food “Tofu” , 2017, PloS one.

[60]  M. Salami,et al.  Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial , 2016, Front. Aging Neurosci..

[61]  K. Fassbender,et al.  Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.

[62]  B. Johnston,et al.  Probiotics and the Prevention of Antibiotic-Associated Diarrhea in Infants and Children. , 2016, JAMA.

[63]  K. Yokoyama,et al.  Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis. , 2016, Journal of dairy science.

[64]  N. Jetté,et al.  The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis , 2016, Neuroepidemiology.

[65]  H. Y. Lee,et al.  Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits , 2016, Molecular Psychiatry.

[66]  X. Wu,et al.  Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress , 2015, Neuroscience.

[67]  R. Baldessarini,et al.  Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials , 2015, The international journal of neuropsychopharmacology.

[68]  Yasunori Nakamura,et al.  Lactobacillus helveticus–fermented milk improves learning and memory in mice , 2015, Nutritional neuroscience.

[69]  E. Dinleyici,et al.  The history of probiotics: the untold story. , 2015, Beneficial microbes.

[70]  K. Barrett,et al.  Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[71]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[72]  Dong-Hyun Kim,et al.  Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a D-galactose-induced accelerated aging mouse model. , 2014, Anaerobe.

[73]  K. Tillisch The effects of gut microbiota on CNS function in humans , 2014, Gut microbes.

[74]  Zhiqiang Liu,et al.  Treatment of Allergic Rhinitis with Probiotics: An Alternative Approach , 2013, North American journal of medical sciences.

[75]  V. Young,et al.  Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. , 2013, Gastroenterology.

[76]  Ksenija Uroić,et al.  Proteolytic activity of probiotic strain Lactobacillus helveticus M92. , 2013, Anaerobe.

[77]  Maria Kechagia,et al.  Health Benefits of Probiotics: A Review , 2013, ISRN nutrition.

[78]  M. Han,et al.  Lactobacillus pentosus var. plantarum C29 protects scopolamine‐induced memory deficit in mice , 2012, Journal of applied microbiology.

[79]  V. Théodorou,et al.  Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats , 2012, Psychoneuroendocrinology.

[80]  Á. Gil,et al.  Probiotic Mechanisms of Action , 2012, Annals of Nutrition and Metabolism.

[81]  Katherine H. Huang,et al.  A framework for human microbiome research , 2012, Nature.

[82]  Toshihide Kobayashi,et al.  Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models , 2012, Immunopharmacology and immunotoxicology.

[83]  J. Wells Immunomodulatory mechanisms of lactobacilli , 2011, Microbial cell factories.

[84]  M. Messaoudi,et al.  Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers , 2011, Gut microbes.

[85]  Kuo-Chen Chou,et al.  A Multi-Label Classifier for Predicting the Subcellular Localization of Gram-Negative Bacterial Proteins with Both Single and Multiple Sites , 2011, PloS one.

[86]  F. Spertini,et al.  Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[87]  G. Riezzo,et al.  Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants , 2011, European journal of clinical investigation.

[88]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[89]  R. Kumar,et al.  Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague–Dawley rats , 2010, British Journal of Nutrition.

[90]  L. Chuang,et al.  Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora , 2010, Clinical Oral Investigations.

[91]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[92]  J. Rhee,et al.  Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders , 2010, Proceedings of the National Academy of Sciences.

[93]  P. Scully,et al.  Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses , 2009, Biological Psychiatry.

[94]  S. Salminen,et al.  Handbook of Probiotics and Prebiotics , 2008 .

[95]  S. D. De Keersmaecker,et al.  Supporting Probiotic Action Genes and Molecules of Lactobacilli Genes and Molecules of Lactobacilli Supporting Probiotic Action Mechanisms of Health-promoting Effects of Lactobacilli: Probiotic Factors..747 , 2022 .

[96]  S. Im,et al.  Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. , 2008, Molecular immunology.

[97]  Ji Yeun Kim,et al.  Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. , 2008, Journal of microbiology and biotechnology.

[98]  R. Rao,et al.  Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[99]  V. Korolik,et al.  Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.

[100]  K. Fellermann,et al.  Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2 , 2008, Clinical and experimental immunology.

[101]  W. Walker Mechanisms of action of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  G. Vinderola,et al.  Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria , 2007, Clinical and Vaccine Immunology.

[103]  T. Tompkins,et al.  Surface‐layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells , 2007, Cellular microbiology.

[104]  G. Perdigón,et al.  The Probiotic Bacterium Lactobacillus casei Induces Activation of the Gut Mucosal Immune System through Innate Immunity , 2006, Clinical and Vaccine Immunology.

[105]  R. Bibiloni,et al.  VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis , 2005, The American Journal of Gastroenterology.

[106]  S. Nuding,et al.  NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium , 2004, Infection and Immunity.

[107]  R. Bourdet-Sicard,et al.  Lactobacillus casei reduces CD8+ T cell‐mediated skin inflammation , 2004, European journal of immunology.

[108]  A. Saggioro Probiotics in The Treatment of Irritable Bowel Syndrome , 2004, Journal of clinical gastroenterology.

[109]  N. Barden CRSN Symposium : Focus on Depression , Part I Symposium du CRSN : le point sur la dépression , première partie Implication of the hypothalamic – pituitary – adrenal axis in the physiopathology of depression , 2004 .

[110]  G. Reid Safety of lactobacillus strains as probiotic agents. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[111]  J. Gruenwald,et al.  Effect of a probiotic multivitamin compound on stress and exhaustion , 2002, Advances in therapy.

[112]  Michelle M. Garrison,et al.  Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. , 2002, Pediatrics.

[113]  N. Sipsas,et al.  Lactobacillus rhamnosus endocarditis complicating colonoscopy. , 2001, The Journal of infection.

[114]  S. Salminen,et al.  Probiotics in the management of atopic eczema , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[115]  K. Kailasapathy,et al.  Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. , 2000, Immunology and cell biology.

[116]  F. Rouillon Anxiety with depression: a treatment need , 1999, European Neuropsychopharmacology.

[117]  H. Kauma,et al.  Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[118]  H. Szajewska,et al.  Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. , 1998, Journal of pediatric gastroenterology and nutrition.

[119]  H. Mykkänen,et al.  Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. , 1997, The Pediatric infectious disease journal.

[120]  C. Singer,et al.  Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. , 1997, Journal of travel medicine.

[121]  D. Harty,et al.  Enzyme production by lactobacilli and the potential link with infective endocarditis. , 1995, The Journal of applied bacteriology.

[122]  D. Lilly,et al.  Probiotics: Growth-Promoting Factors Produced by Microorganisms , 1965, Science.

[123]  T. Fog,et al.  [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.

[124]  Dong Hyun Kim,et al.  Lactobacillus mucosae and Bifidobacterium longum synergistically alleviate immobilization stress-induced anxiety/depression in mice by suppressing gut dysbiosis. , 2019, Journal of microbiology and biotechnology.

[125]  J. Segura-Aguilar,et al.  Protective Effects of Crude Plant Extracts against Aminochrome-induced toxicity in Human Astrocytoma Cells: Implications for Parkinson's Disease. , 2019, Clinical pharmacology and translational medicine.

[126]  Ren-Long Jan,et al.  Lactobacillus gasseri attenuates allergic airway inflammation through PPARγ activation in dendritic cells , 2017, Journal of Molecular Medicine.

[127]  W. Pace,et al.  Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. , 2012, Clinical therapeutics.

[128]  R. Probiotics in man and animals , 2008 .

[129]  M. H. Kontroab,et al.  Communicating Current Research and Educational Topics and Trends in Applied Microbiology , 2007 .

[130]  G. Reid,et al.  Probiotics: 100 years (1907-2007) after Elie Metchnikoff's Observations , 2007 .

[131]  G. Reid,et al.  Oral Administration of the Probiotic Combination Lactobacillus Rhamnosus GR-1 and L. Fermentum RC-14 for Human Intestinal Applications , 2002 .

[132]  M. Kalliomäki,et al.  Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. , 2002, The Journal of allergy and clinical immunology.

[133]  B. Mollet,et al.  Biotechnological Research and the Dairy Industry , 2001 .

[134]  M. Hollingsworth,et al.  Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[135]  G. Tannock,et al.  Probiotics for farm animals. , 1999 .